Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yen-Lin Chee

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cancer Reports (Hoboken, N.J.)|April 28, 2022
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapyTricia Tay, Nagavalli Somasundaram, Cindy Lim, et al.
Nature Communications|March 8, 2024
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphomaMin Liu, Giorgio Bertolazzi, Shruti Sridhar, et al.
JCO Precision Oncology|July 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's LymphomaRui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib, et al.
Thrombosis Journal|March 9, 2021
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in SingaporeChuen Wen Tan, Bingwen Eugene Fan, Winnie Z Y Teo, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Cancer Discovery|April 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in LymphomaMichal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Reports (Hoboken, N.J.)|April 28, 2022
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapyTricia Tay, Nagavalli Somasundaram, Cindy Lim, et al.
Nature Communications|March 8, 2024
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphomaMin Liu, Giorgio Bertolazzi, Shruti Sridhar, et al.
JCO Precision Oncology|July 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's LymphomaRui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib, et al.
Thrombosis Journal|March 9, 2021
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in SingaporeChuen Wen Tan, Bingwen Eugene Fan, Winnie Z Y Teo, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Cancer Discovery|April 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in LymphomaMichal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, et al.
Pageof 4